Information Library

Product Development & Commercialization - Market Access

To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.

See all

  • Sort by:
  • Most Recent
  • Title

  • PharmAsia News Article Reprint

    March 1, 2010
    Quintiles Asia Executives Say CROs Must Evaluate, Adjust To New Health Landscape: An Interview With PharmAsia News.

  • Rewarding Innovation and Value: What is the Role of Comparative Effectiveness Research

    October 6, 2009
    The impact of comparative effectiveness research on the future of drug development.

  • Orphan Drugs in the U.S.

    June 24, 2009
    Presentation by Dr. John Doyle, Market Access Practice Leader, from ISPOR 14th Annual International Meeting 2009(International Society for Pharmacoeconomics and Outcomes Research) on “Orphan Drugs' Market Access in the U.S.”

  • Poised for success

    June 16, 2009
    Learn how a holistic life cycle approach can improve your commercial organization's productivity and flexibility

  • Robert A. Pearlstein

    March 25, 2009
    Bob is a co-founder of Eidetics, and has over two decades of experience assessing commercial opportunities and creating product strategies for biopharma and medical device clients worldwide.

  • George A. Mabry

    March 25, 2009
    George joined Eidetics in 1989 after a successful career in consumer and industrial products marketing and strategic planning. He previously held product management positions at General Foods and senior marketing management positions at Teradyne.

  • Frederick M. Gale, MD, FACS

    March 25, 2009
    A co-founder of Eidetics, Frederick brings over 20 years of experience in strategic research and consulting support for the pharmaceutical, biotech, and medical device industries.

  • Matthew Eberhart

    March 25, 2009
    Matt is a proven business-building executive with a strong track record of implementing successful business development initiatives for consulting healthcare companies in both North America and Europe.

  • Jay Norman

    March 24, 2009
    President – Quintiles Consulting Jay brings 25 years of experience in the consulting industry and a strong track record of growth, most recently with Diamond Management and Technology Consultants, where he served as President and Chief Operating Officer.

Page 1 of 1 (9 results)

Tell Us What You Think

Rate your Quintiles.com experience

Subscribe to Email Based on Your Interests

Set preferences